
|

| |
Track this Pro and follow
their portfolio moves with tickerspy™ alerts |
 |
|
 | Nsb Advisors LLC |
| |
Performance |
|
|
|
Similar Pro Portfolios |
|
|
|
Community |
|
| |
Today:
Week:
1-month:
All-time:
|
-0.9%
-11.4%
-20.2%
-1.6%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
-0.5%
-9.1%
-15.7%
-22.0%
|
Data since: Jan-1-2010 Current Portfolio: Q4 2011
|
|
|
|
|
|
|
|
|
Share this Pro on Facebook
Share this Pro on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |

 |
Click
a column to sort | Scroll over columns for more information |
|
|
| AGX |
$14.28 |
-0.17 |
-1.18% |
81,969 |
72% |
$195.0M |
- |
60% |
-19% |
-6.1% |
$73.4M | 4.8M shares - increase of 81.4K shares
No Alerts/News
|
|
|
| AMGN |
$70.98 |
+0.30 |
+0.42% |
3,410,911 |
86% |
$55.4B |
2.0% |
49% |
-1% |
+10.5% |
$2.8M | 43.5K shares - No Change
1 Alert (0 News) - View
|
|
|
| ATRO |
$28.04 |
-0.41 |
-1.44% |
35,676 |
93% |
$346.8M |
- |
20% |
-26% |
-21.7% |
$104.8M | 2.9M shares - increase of 28.2K shares
No Alerts/News
|
|
|
| CELG |
$70.72 |
-0.48 |
-0.67% |
2,806,015 |
83% |
$31.1B |
- |
37% |
-12% |
+4.6% |
$4.3M | 64.2K shares - No Change
No Alerts/News
|
|
|
| EEI |
$14.41 |
+0.01 |
+0.07% |
500 |
16% |
$61.1M |
3.3% |
3% |
-37% |
-10.8% |
$3.2M | 195.4K shares - increase of 36.6K shares
No Alerts/News
|
|
|
| EML |
$19.63 |
-0.12 |
-0.61% |
4,224 |
91% |
$121.9M |
2.0% |
25% |
-26% |
-1.9% |
$56.9M | 2.8M shares - increase of 53.4K shares
No Alerts/News
|
|
|
| GCOM |
$11.30 |
+0.02 |
+0.18% |
392,336 |
401% |
$260.3M |
- |
13% |
-31% |
-17.4% |
$146.8M | 10.7M shares - increase of 408.2K shares
No Alerts/News
|
|
|
| GHM |
$19.30 |
-0.09 |
-0.46% |
23,933 |
66% |
$191.8M |
0.4% |
34% |
-23% |
-14.0% |
$11.4M | 509.9K shares - increase of 387.1K shares
No Alerts/News
|
|
|
| GLPW |
$18.74 |
-0.23 |
-1.21% |
117,570 |
194% |
$316.9M |
- |
0% |
-38% |
-21.1% |
$119.0M | 5.0M shares - increase of 571.1K shares
1 Alert (0 News) - View
|
|
|
| GVP |
$2.50 |
+0.05 |
+2.04% |
288,067 |
231% |
$46.0M |
- |
67% |
-17% |
+28.2% |
$4.9M | 2.5M shares - increase of 7.5K shares
No Alerts/News
|
|
|
| PMFG |
$9.13 |
-0.08 |
-0.87% |
136,022 |
97% |
$188.8M |
- |
-0% |
-67% |
-53.2% |
$253.6M | 13.0M shares - increase of 249.9K shares
1 Alert (0 News) - View
|
|
|
| RAND |
$2.85 |
-0.09 |
-2.93% |
9,711 |
48% |
$19.4M |
- |
14% |
-32% |
-8.1% |
$7.7M | 2.5M shares - increase of 73.8K shares
No Alerts/News
|
|
|
| SDS |
$16.80 |
+0.13 |
+0.76% |
21,416,810 |
115% |
$ |
- |
14% |
-42% |
-12.9% |
$5.8M | 300.8K shares - decrease of 5.2K shares
1 Alert (0 News) - View
|
|
|
| TRNS |
$8.34 |
-0.16 |
-1.88% |
12,322 |
58% |
$61.1M |
- |
3% |
-40% |
-27.5% |
$54.3M | 4.7M shares - increase of 74.3K shares
1 Alert (0 News) - View
|
|
|
| USLM |
$46.77 |
-0.85 |
-1.78% |
13,762 |
185% |
$259.4M |
- |
26% |
-31% |
-22.2% |
$68.9M | 1.1M shares - increase of 43.7K shares
1 Alert (0 News) - View
|
|
|
|
|
Discuss Nsb Advisors LLC 's portfolio
|
|
|
|
| |

|
| |
|
| |

|
| |
Agennix AG Reports Financial Results for First Quarter of 2012 AGX
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 09, 01:39AM from (www2.marketwire.com) Agennix AG (FRANKFURT: AGX) (XETRA: AGX), a biopharmaceutical company focused on developing novel therapies that have the
Flag
Post a comment
Biotechs Bucking The Dendreon Trap & Curse AMGN SVNT VRTX VVUS ARNA DNDN ALNY
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 08, 01:15PM from (247wallst.com) When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a chance
Flag
Post a comment
Actelion Lung Drug Meets Main Goal in Pivotal Patient Study AMGN GILD
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - April 30, 01:32AM from (www.bloomberg.com) Actelion Ltd. (ATLN)’s experimental lung drug macitentan met the main goal of a late-stage clinical trial, providing the
Flag
Post a comment
AstraZeneca C.E.O. to Step Down BMY PFE AMGN TRGT
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - April 26, 10:37AM from (feeds.nytimes.com) David Brennan is leaving as the big British pharmaceutical company struggles with generic competition and lower revenue and
Flag
Post a comment
Aflac, Apple, Baidu, Panera, RF: U.S. Equity Preview AFL AMGN AAPL IGT NSC PNRA USNA RFMD LIFE BIDU
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - April 24, 05:36PM from (www.bloomberg.com) Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses, and prices are as of 4:50 p.m. in New York.
Flag
Post a comment
Amgen Q1 Profit and Revenue Beat Expectations AMGN
Linked by The Dividend Daily ( track newsfeed | ignore newsfeed ) - April 24, 04:50PM from (www.dividend.com) Biotechnology specialist Amgen Inc. (AMGN) late Tuesday said its first quarter earnings rose 5% from last year, beating Wall
Flag
Post a comment
Amgen Profit Tops Analysts' Estimate on Rising Drug Sales AMGN
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - April 24, 04:37PM from (www.bloomberg.com) Amgen Profit Tops Analysts’ Estimates on Drug Revenue Increases
Signage is seen at Amgen Inc. headquarters in Thousand Oaks, California.
Flag
Post a comment
George Rathmann, Chief of Amgen, Dies at 84 ABT MMM AMGN MSFT
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - April 23, 09:15PM from (feeds.nytimes.com) Dr. Rathmann oversaw Amgen as it developed what would become two of the most successful drugs in history and became the world’s
Flag
Post a comment
Top Earnings Previews For Early In The Week Ahead MMM TXN UTX AMGN AAPL T JNPR NFLX ILMN COH COP X RF BIDU
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - April 20, 02:35PM from (247wallst.com) Earnings season is in full swing and we have many key reports due in the coming week. 24/7 Wall St. has provided some detailed
Flag
Post a comment
|
|